A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

Hereditary angioedema, known as HAE, represents one of medicine’s most perplexing conditions. This rare genetic disorder manifests through unpredictable and potentially dangerous swelling episodes ...

Optimize your hereditary angioedema (HAE) care management with the help of an allergist-immunologist, PCP, gastroenterologist ...

Understand the differences between hereditary and histamine-mediated angioedema, including their symptoms, causes, and treatments.

Please provide your email address to receive an email when new articles are posted on . The patient, aged 66 years, had no previous edema. The patient tested positive for a mutation in the plasminogen ...

LOUISVILLE, Ky. -- The future medical promise of CRISPR/Cas9 gene-editing appears to be a present-day reality for a small group of patients with the rare genetic condition known as hereditary ...

Deficiency of functional C1-INH activity is an autosomal dominant genetic disorder that can be further classified into 2 types. Type I HAE, which accounts for approximately 85% of cases, occurs due to ...

A new study shows a treatment using the CRISPR genome editing technology succeeded in alleviating swelling and reducing the frequency of attacks for those with hereditary angioedema. Hereditary ...

T he severe swelling of hereditary angioedema (HAE) can be uncomfortable and inconvenient at best, life-threatening at worst. What’s more, symptoms are unpredictable, vary in severity, and crop up out ...

Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on Friday that a pair of late-stage trials showed that its experimental therapy for ...